Cell Expansion Market

Market Insights

The cell expansion market is set to grow from US$ 9,743.7 million in 2018 to US$ 33,443.2 million by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. The lack of an effective treatment regime for chronic disease has resulted in a significant rise in novel drug discovery and development research studies throughout the globe. Increasing demand for regenerative medicine and stem cell therapy further consolidates the cell expansion market’s growth.

Market Synopsis

A significant rise in high-throughput screening has resulted in increasing consumption of consumables during the novel drug discovery and development stage.

Consumables reign over the product segment for the cell expansion market. The chief contributing factor responsible for its positive market growth is the significant rise in high-throughput screening, which increases the consumption of consumables during the novel drug discovery and development stages. Disposables will be growing at a rampant pace during the forecast period owing to the negligible risk of cross-contamination of laboratory equipment and the flourishing biotechnology and pharmaceutical industries.

Significant growth in translational research related to molecular biology and tissue engineering increases the demand for regenerative medicine.

Regenerative medicine is dominating the application segment of the cell expansion market. In the last two decades, there has been significant growth in translational research pertaining to molecular biology and tissue engineering. Regenerative medicine is widely employed in restoring the normal function of cells and tissues of internal organs. Increasing demand for personalized medicine has created a lucrative market opportunity for the growth of regenerative medicine. Clinical diagnostics are garnering the attention of researchers around the globe due to technological advancements in companion diagnostic kits and rising public health awareness, resulting in early screening of chronic diseases.

Rising prevalence of chronic disease and increasing demand for regenerative medicine together drive the market growth in North America.

North America, with a market share of 35.2%, is spearheading the regional segment for the cell expansion market. The major factors influencing its market growth are the rising prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), the statistics provided by the National Health Council indicate that approximately 133 million Americans are suffering from chronic diseases. Tremendous demand for the development of regenerative medicine further propels market growth in the North American region.

Europe represents a market share of 30.5% on account of the domicile of major biopharmaceutical companies such as Becton Dickinson & Company, Merck Millipore, GE Healthcare, etc. Asia Pacific presently holds 17.5% of the market share owing to the developing healthcare infrastructure and supportive regulatory environment provided by local healthcare agencies for the proliferation of cell expansion products.

Historical and Forecast Period

This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market is segmented by product, application, and geography.Medical device companies spearheading the cell expansion market are Becton Dickinson & Company, Beckman Coulter, Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Miltenyi Biotec, STEMCELL Technologies, Terumo Biotec, and Thermo Fisher Scientific.

Key questions are answered in this report.

• Which major players are competing in the cell expansion market?
• What are the organic and inorganic market growth strategies being adopted to perform the market assessment for the cell expansion market?
• Which factors are responsible for the increasing demand for stem cell therapy and regenerative medicine?
• Which factors are responsible for the increasing consumption of consumables in pharmaceutical and biotechnology companies?
• What is the market performance in the developed regions of North America and Europe?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global CE Market Portraiture
2.2. Global CE Market, by Product, 2018 (US$ Mn)
2.3. Global CE Market, by Application, 2018 (US$ Mn)
2.4. Global CE Market, by Geography, 2018 (US$ Mn)

Chapter 3. Cell Expansion (CE) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global CE Market, by Key Players, 2018

Chapter 4. Global Cell Expansion (CE) Market, by Product
4.1. Overview
4.2. Instrument
4.3. Consumables
4.4. Disposables

Chapter 5. Global Cell Expansion (CE) Market, by Application
5.1. Overview
5.2. Regenerative Medicine
5.3. Cancer & Stem Cell Research
5.4. Clinical Diagnostics
5.5. Others

Chapter 6. Global Cell Expansion (CE) Market, by Geography
6.1. Overview
6.2. North America CE Market Analysis, 2017– 2027
6.2.1. North America CE Market, by Product, 2017 – 2027 (US$ Mn)
6.2.2. North America CE Market, by Application, 2017 – 2027 (US$ Mn)
6.2.3. North America CE Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe CE Market Analysis, 2017 – 2027
6.3.1. Europe CE Market, by Product, 2017– 2027 (US$ Mn)
6.3.2. Europe CE Market, by Application, 2017 – 2027 (US$ Mn)
6.3.3. Europe CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific CE Market Analysis, 2017 – 2027
6.4.1. Asia Pacific CE Market, by Product, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific CE Market, by Application, 2017– 2027 (US$ Mn)
6.4.3. Asia Pacific CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America CE Market Analysis, 2017 – 2027
6.5.1. Latin America CE Market, by Product, 2017 – 2027 (US$ Mn)
6.5.2. Latin America CE Market, by Application, 2017 – 2027 (US$ Mn)
6.5.3. Latin America CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa CE Market Analysis, 2017 – 2027
6.6.1. MEA CE Market, by Product, 2017 – 2027 (US$ Mn)
6.6.2. MEA CE Market, by Application, 2017 – 2027 (US$ Mn)
6.6.3. MEA CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Becton Dickinson & Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Beckman Coulter, Inc.
7.3. Corning Incorporation
7.4. Danaher Corporation
7.5. GE Healthcare
7.6. Merck Millipore
7.7. Miltenyi Biotec
7.8. STEMCELL Technologies
7.9. Terumo BCT
7.10. Thermo Fisher Scientific

List of Figures

FIG. 1 Cell Expansion (CE) Market: Research Methodology
FIG. 2 CE: Market Segmentation
FIG. 3 Global CE Market, by Product, 2018 (US$ Mn)
FIG. 4 Global CE Market, by Application, 2018 (US$ Mn)
FIG. 5 Global CE Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global CE Market, by Key Players, 2018
FIG. 8 Global Instrument CE Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Consumables CE Market, 2017– 2027 (US$ Mn)
FIG. 10 Global Disposables CE Market, 2017 – 2027 (US$ Mn)
FIG. 11 Global Regenerative Medicine Market for CE, 2017 – 2027 (US$ Mn)
FIG. 12 Global Cancer & Stem Cell Research Market for CE, 2017 – 2027 (US$ Mn)
FIG. 13 Global Clinical Diagnostics Market for CE, 2017 – 2027 (US$ Mn)
FIG. 14 Global Other Applications Market for CE, 2017 – 2027 (US$ Mn)
FIG. 15 U.S. CE Market, 2017 – 2027 (US$ Mn)
FIG. 16 Canada CE Market, 2017 – 2027 (US$ Mn)
FIG. 17 U.K. CE Market, 2017 – 2027 (US$ Mn)
FIG. 18 Germany CE Market, 2017– 2027 (US$ Mn)
FIG. 19 Rest of Europe CE Market, 2017 – 2027 (US$ Mn)
FIG. 20 China CE Market, 2017 – 2027 (US$ Mn)
FIG. 21 Japan CE Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Asia Pacific CE Market, 2017 – 2027 (US$ Mn)
FIG. 23 Brazil CE Market, 2017 – 2027 (US$ Mn)
FIG. 24 Mexico CE Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Latin America CE Market, 2017 – 2027 (US$ Mn)
FIG. 26 GCC CE Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of MEA CE Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Cell Expansion (CE) Market Portraiture
TABLE 2 Global CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 3 Global CE Market , by Application, 2017 – 2027 (US$ Mn)
TABLE 4 Global CE Market, by Geography, 2017 – 2027(US$ Mn)
TABLE 5 North America CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 6 North America CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 7 North America CE Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 9 Europe CE Market, by Application, 2017 – 2027(US$ Mn)
TABLE 10 Europe CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific CE Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 14 Latin America CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Becton Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Corning Incorporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Merck Millipore: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Miltenyi Biotec: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 STEMCELL Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Terumo BCT: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Thermo Fisher Scientific: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)